Drug Profile
IWF 12214
Alternative Names: AWD 12214Latest Information Update: 02 Sep 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Cardiotonics; Small molecules
- Mechanism of Action Type 3 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 26 Jan 2002 Discontinued-unspecified phase for Heart Failure